Free Trial
NASDAQ:PTPI

Petros Pharmaceuticals (PTPI) Stock Price, News & Analysis

Petros Pharmaceuticals logo
$0.02 0.00 (-1.77%)
As of 10/14/2025 03:16 PM Eastern

About Petros Pharmaceuticals Stock (NASDAQ:PTPI)

Advanced

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.03
52-Week Range
$0.02
$16.25
Volume
229,315 shs
Average Volume
4.13 million shs
Market Capitalization
$691.75 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PTPI Stock News Headlines

Petros Pharmaceuticals Inc (PTPI) - Investing.com
Magnificent 7 being replaced by the “Hidden 7”?
BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on some of the biggest winners of 2025.tc pixel
Petros Pharmaceuticals, Inc. (PTPI) - Yahoo Finance
See More Headlines

PTPI Stock Analysis - Frequently Asked Questions

Petros Pharmaceuticals' stock was trading at $9.8475 at the beginning of the year. Since then, PTPI stock has decreased by 99.8% and is now trading at $0.0222.

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) announced its earnings results on Thursday, May, 15th. The company reported ($8.46) earnings per share for the quarter.

Petros Pharmaceuticals's stock reverse split on Thursday, May 1st 2025.The 1-25 reverse split was announced on Tuesday, April 29th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of PTPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Petros Pharmaceuticals investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), Bank of America (BAC), Abbott Laboratories (ABT), Cricut (CRCT) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
5/15/2025
Today
10/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PTPI
CIK
1815903
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($52.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.16 million
Net Margins
N/A
Pretax Margin
-117.50%
Return on Equity
-78.22%
Return on Assets
-23.50%

Debt

Debt-to-Equity Ratio
1.58
Current Ratio
0.85
Quick Ratio
0.74

Sales & Book Value

Annual Sales
$5.11 million
Price / Sales
0.14
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
31,160,000
Free Float
9,932,000
Market Cap
$691.75 thousand
Optionable
Not Optionable
Beta
1.64
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:PTPI) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners